Solid Biosciences Inc. (SLDB) ROA
- 2026-06-30: ROA -49.24%.
- 2026-03-31: ROA -45.35%.
- 2025-12-31: ROA -74.97%.
- 2025-09-30: ROA -61.02%.
Complete source-backed roa history.
- Available history
- 2017-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|
| 2026-06-30 | -49.24% |
|---|
| 2026-03-31 | -45.35% |
|---|
| 2025-12-31 | -74.97% |
|---|
| 2025-09-30 | -61.02% |
|---|
| 2025-06-30 | -49.98% |
|---|
| 2025-03-31 | -40.61% |
|---|
| 2024-12-31 | -66.10% |
|---|
| 2024-09-30 | -48.36% |
|---|
| 2024-06-30 | -39.26% |
|---|
| 2024-03-31 | -36.29% |
|---|
| 2023-12-31 | -58.21% |
|---|
| 2023-09-30 | -49.17% |
|---|
| 2023-06-30 | -44.09% |
|---|
| 2023-03-31 | -39.52% |
|---|
| 2022-12-31 | -33.04% |
|---|
| 2022-09-30 | -48.48% |
|---|
| 2022-06-30 | -41.73% |
|---|
| 2022-03-31 | -38.84% |
|---|
| 2021-12-31 | -31.06% |
|---|
| 2021-09-30 | -30.10% |
|---|
| 2021-06-30 | -29.42% |
|---|
| 2021-03-31 | -27.52% |
|---|
| 2020-12-31 | -51.58% |
|---|
| 2020-09-30 | -243.81% |
|---|
| 2020-06-30 | -184.25% |
|---|
| 2020-03-31 | -154.59% |
|---|
| 2019-12-31 | -113.29% |
|---|
| 2019-09-30 | -81.94% |
|---|
| 2019-06-30 | -100.77% |
|---|
| 2019-03-31 | -73.61% |
|---|
| 2018-12-31 | -53.58% |
|---|
| 2018-09-30 | -42.96% |
|---|
| 2018-06-30 | -36.07% |
|---|
| 2018-03-31 | -29.16% |
|---|
| 2017-12-31 | -68.40% |
|---|
Annual ROA
| Date | ROA |
|---|
| 2025-12-31 | -74.97% |
|---|
| 2024-12-31 | -66.10% |
|---|
| 2023-12-31 | -58.21% |
|---|
| 2022-12-31 | -33.04% |
|---|
| 2021-12-31 | -31.06% |
|---|
| 2020-12-31 | -51.58% |
|---|
| 2019-12-31 | -113.29% |
|---|
| 2018-12-31 | -53.58% |
|---|
| 2017-12-31 | -68.40% |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
|---|
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
|---|
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
|---|
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
|---|
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
|---|
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
|---|
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
|---|
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
|---|
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
|---|